Targeting the androgen receptor (AR) in women with AR+ ER-/PR- metastatic breast cancer (MBC).Ayca Gucalp, Tiffany A. Traina, Steven J. Isakoff et al.|Journal of Clinical Oncology|2012Cited by 31